Cargando…
Immunohistochemical Expression of CD44, MMP-2, MMP-9, and Ki-67 as the Prognostic Markers in Non-Clear Cell Renal Cell Carcinomas—A Prospective Cohort Study
CD44 is the most frequently reported marker of the cancer stem cells in renal cell carcinoma (RCC). Matrix metalloproteinases MMP-2 and MMP-9 are key regulators of tumor invasion and metastasis. The aim of this study was to investigate the clinicopathologic and prognostic values of the immunohistoch...
Autores principales: | Chrabańska, Magdalena, Rynkiewicz, Magdalena, Kiczmer, Paweł, Drozdzowska, Bogna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457518/ https://www.ncbi.nlm.nih.gov/pubmed/36079127 http://dx.doi.org/10.3390/jcm11175196 |
Ejemplares similares
-
Does the Immunohistochemical Expression of CD44, MMP-2, and MMP-9 in Association with the Histopathological Subtype of Renal Cell Carcinoma Affect the Survival of Patients with Renal Cancer?
por: Chrabańska, Magdalena, et al.
Publicado: (2023) -
Lung Cancer Cytology: Can Any of the Cytological Methods Replace Histopathology?
por: Chrabańska, Magdalena, et al.
Publicado: (2020) -
Two Single Nucleotide Polymorphisms in the Von Hippel-Lindau Tumor Suppressor Gene in Patients with Clear Cell Renal Cell Carcinoma
por: Chrabańska, Magdalena, et al.
Publicado: (2023) -
Immunohistochemical expression of hormone receptors, Ki-67, endoglin (CD105), claudins 3 and 4, MMP-2 and -9 in endometrial polyps and endometrial cancer type I
por: Peres, Gustavo Filipov, et al.
Publicado: (2018) -
Periostin in Angiogenesis and Inflammation in CRC—A Preliminary Observational Study
por: Kula, Agnieszka, et al.
Publicado: (2022)